Circulating tumor DNA (ctDNA) is a promising biomarker for monitoring treatment response and progression-free survival in ...

The strange thing about having terminal cancer at 37 is that, in some ways, I’m much happier than I had been before my ...

New longitudinal research reveals that severe stress caused by changes in family structure like divorce or separation ...

A research team from the University of Zurich and the University Children's Hospital Zurich has developed a new approach for treating children with malignant tumors of the nervous system.

For the past two decades, biology textbooks have described CENP-E as a motor protein that moves along microtubules. The ...

Mitochondrial dysfunction triggered by ER stress was found to make Tregs unstable and to cause them to lose their protective ...

CStone Pharmaceuticals ( OTCPK:CSPHF) Discusses CS2009 Data Interpretation and Future Clinical Development Strategy October 20, 2025 9:00 AM EDT ...

Scientists at the Ruđer Bošković Institute (RBI) in Zagreb, Croatia, have discovered that the protein CENP-E, long believed ...

The federal government has been—and must remain—a critical partner in foundational technological innovation and research ...

In a Phase III trial, sacituzumab tirumotecan outperformed chemo in previously treated EGFR-mutant NSCLC patients, results presented at the ESMO Congress show.

Researchers believe a groundbreaking new drug can offer hope to those diagnosed with this deadly breast cancer, creating a ...